NEW
3D-EXPRESS
Built upon our core 3D-EXplore platform, 3D-EXpress is a translational ex-vivo program designed to rapidly test immuno-oncology and oncology therapeutics using 3D tumoroids created from fresh patient tumors. Our tumoroids are never dissociated, propagated, or reassembled.
-
ISOLATION AND CHARACTERIZATION OF FRESH TUMOR TISSUE
-
CONVERSION INTO 3D TUMOROIDS
-
POOLING OF TUMOROIDS TO OVERCOME TUMOR HETEROGEINITY
-
ALIQUOTING OF TUMOROIDS AND CRYOPRESERVATION
-
EX VIVO TREATMENT OF PRESELECTED TUMOROIDS WITH CANDIDATE THERAPIES
WHAT IS 3D-EXPRESS?
Select pre-characterized tumors in our existing biorepository to generate actionable data by assessing target binding, stromal penetration and tumor cell killing of your drug and drug combinations using high content confocal imaging while analyzing conditioned media for cytokine release to monitor treatment-mediated changes in the tumor immune microenvironment.